Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2015, Article ID 124507, 5 pages
http://dx.doi.org/10.1155/2015/124507
Clinical Study

Evaluation of the Effects of Charged Amino Acids on Uncontrolled Seizures

Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran

Received 13 March 2015; Revised 15 June 2015; Accepted 25 June 2015

Academic Editor: Changiz Geula

Copyright © 2015 Hossein Ali Ebrahimi and Saeed Ebrahimi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. S. Bell and J. W. Sander, “The epidemiology of epilepsy: the size of the problem,” Seizure, vol. 10, pp. 306–331, 2001. View at Google Scholar
  2. J. W. A. S. Sander and S. D. Shorvon, “Epidemiology of the epilepsies,” Journal of Neurology Neurosurgery and Psychiatry, vol. 61, no. 5, pp. 433–443, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. P. N. Banerjee, D. Filippi, and W. Allen Hauser, “The descriptive epidemiology of epilepsy—a review,” Epilepsy Research, vol. 85, no. 1, pp. 31–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Ebrahimi, M. A. Shafa, and S. Hakimzadeh Asl, “Prevalence of active epilepsy in Kerman, Iran: a house based survey,” Acta Neurologica Taiwanica, vol. 21, no. 3, pp. 114–124, 2012. View at Google Scholar
  5. K. Radhakrishnan and M. B. Rao, in Epilepsy in India, B. S. Singhal and D. Nag, Eds., pp. 343–362, Indian Epilepsy Association, Mumbai, India, 2000.
  6. G. Regesta and P. Tanganelli, “Clinical aspects and biological bases of drug-resistant epilepsies,” Epilepsy Research, vol. 34, no. 2-3, pp. 109–122, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. French, “Refractory epilepsy: clinical overview,” Epilepsia, vol. 48, supplement 1, pp. 3–8, 2007. View at Publisher · View at Google Scholar
  8. O. Devinsky, “Patients with refractory seizures,” The New England Journal of Medicine, vol. 340, pp. 1565–1570, 1999. View at Publisher · View at Google Scholar
  9. K. Radhakrishnan, “Challenges in the management of epilepsy in resource-poor countries,” Nature Reviews Neurology, vol. 5, no. 6, pp. 323–330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. U. Schuele and H. O. Lüders, “Intractable epilepsy: management and therapeutic alternatives,” The Lancet Neurology, vol. 7, no. 6, pp. 514–524, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Parra, S. N. Kalitzin, and F. H. Lopes da Silva, “Photosensitivity and visually induced seizures,” Current Opinion in Neurology, vol. 18, no. 2, pp. 155–159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. S. Seshia and L. Carmant, “Visual-sensitive epilepsies: classification and review,” Canadian Journal of Neurological Sciences, vol. 32, no. 3, pp. 298–305, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. P. D. Singhi and D. Bansal, “Self induced photosensitive epilepsy,” The Indian Journal of Pediatrics, vol. 71, no. 7, pp. 649–651, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Ebrahimi, “Photoconvulsive epilepsy,” Iranian Journal of Epilepsy, vol. 10, pp. 313–314, 1384. View at Google Scholar
  15. D. C. De Vivo, R. R. Trifiletti, R. I. Jacobson, G. M. Ronen, R. A. Behmand, and S. I. Harik, “Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay,” The New England Journal of Medicine, vol. 325, no. 10, pp. 703–709, 1991. View at Publisher · View at Google Scholar · View at Scopus
  16. I. D. Wexler, S. G. Hemalatha, J. McConnell et al., “Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets: studies in patients with identical mutations,” Neurology, vol. 49, no. 6, pp. 1655–1661, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. E. H. Kossoff, G. L. Krauss, J. R. McGrogan, and J. M. Freeman, “Efficacy of the Atkins diet as therapy for intractable epilepsy,” Neurology, vol. 61, no. 12, pp. 1789–1791, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Evangeliou, M. Spilioti, V. Doulioglou et al., “Branched chain amino acids as adjunctive therapy to ketogenic diet in epilepsy: pilot study and hypothesis,” Journal of Child Neurology, vol. 24, no. 10, pp. 1268–1272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Ebrahimi and M. Asadi, “Effect of charged amino acids on convulsion due to penthylentetrazol in male adult rat,” Iranian Journal of Neurology, vol. 4, no. 12, 2005. View at Google Scholar
  20. J. Vaquero and R. F. Butterworth, “The brain glutamate system in liver failure,” Journal of Neurochemistry, vol. 98, no. 3, pp. 661–669, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Blandini, R. H. P. Porter, and J. T. Greenamyre, “Glutamate and Parkinson's disease,” Molecular Neurobiology, vol. 12, no. 1, pp. 73–94, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. S. M. Rothman and J. W. Olney, “Glutamate and the pathophysiology of hypoxic-ischemic brain damage,” Annals of Neurology, vol. 19, no. 2, pp. 105–111, 1986. View at Publisher · View at Google Scholar · View at Scopus
  23. R. J. Thomas, “Excitatory amino acids in health and disease,” Journal of the American Geriatrics Society, vol. 43, no. 11, pp. 1279–1289, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Lau and M. Tymianski, “Glutamate receptors, neurotoxicity and neurodegeneration,” Pflugers Archiv European Journal of Physiology, vol. 460, no. 2, pp. 525–542, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Erecińska and I. A. Silver, “Metabolism and role of glutamate in mammalian brain,” Progress in Neurobiology, vol. 35, no. 4, pp. 245–296, 1990. View at Publisher · View at Google Scholar · View at Scopus
  26. L. F. Obel, K. M. H. Andersen, L. K. Bak, A. Schousboe, and H. S. Waagepetersen, “Effects of adrenergic agents on intracellular Ca2+ homeostasis and metabolism of glucose in astrocytes with an emphasis on pyruvate carboxylation, oxidative decarboxylation and recycling: implications for glutamate neurotransmission and excitotoxicity,” Neurotoxicity Research, vol. 21, no. 4, pp. 405–417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. W. C. Rose, W. J. Haines, and D. T. Warner, “The amino acid requirements of man. V. The role of lysine, arginine, and tryptophan,” The Journal of Biological Chemistry, vol. 206, no. 1, pp. 421–430, 1954. View at Google Scholar
  28. E. T. Mertz, W. M. Beeson, and H. D. Jackson, “Classification of essential amino acids for the weanling pig,” Archives of Biochemistry and Biophysics, vol. 38, no. 1, pp. 121–128, 1952. View at Publisher · View at Google Scholar · View at Scopus
  29. W. C. Heird, J. F. Nicholson, J. M. Driscoll Jr., J. N. Schullinger, and R. W. Winters, “Hyperammonemia resulting from intravenous alimentation using a mixture of synthetic L-amino acids: a preliminary report,” The Journal of Pediatrics, vol. 81, no. 1, pp. 162–165, 1972. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Barbul, “Arginine: biochemistry, physiology, and therapeutic implications,” Journal of Parenteral and Enteral Nutrition, vol. 10, no. 2, pp. 227–238, 1986. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Wu and S. M. Morris Jr., “Arginine metabolism: nitric oxide and beyond,” Biochemical Journal, vol. 336, no. 1, pp. 1–17, 1998. View at Google Scholar · View at Scopus
  32. S. M. Morris Jr., “Arginine metabolism: boundaries of our knowledge,” The Journal of Nutrition, vol. 137, no. 6, supplement 2, pp. 1602S–1609S, 2007. View at Google Scholar · View at Scopus
  33. H. Eagle, “Amino acid metabolism in mammalian cell cultures,” Science, vol. 130, no. 3373, pp. 432–437, 1959. View at Publisher · View at Google Scholar · View at Scopus
  34. S. M. Morris Jr., “Arginine synthesis, metabolism, and transport: regulators of nitric oxide synthesis,” in Cellular and Molecular Biology of Nitric Oxide, J. D. Laskin and D. L. Laskin, Eds., pp. 57–85, Marcel Dekker, New York, NY, USA, 1999. View at Google Scholar
  35. C. Vianey-Liaud, P. Divry, C. Poinas, and M. Mathieu, “Lysine metabolism in man,” Annales de Biologie Clinique, vol. 49, no. 1, pp. 18–26, 1991. View at Google Scholar · View at Scopus
  36. E. R. Braverman, The Healing Nutrients Within, Keats Publishing, New Canaan, Conn, USA, 1997.
  37. M. P. H. Cooper and H. Kenneth, Advanced Nutritional Therapies, Thomas Nelson, Nashville, Tenn, USA, 1996.
  38. M. D. Balch, F. James, C. N. C. Balch, and A. Phyllis, Prescription for Nutritional Healing, Avery Publishing Group, Garden City Park, NY, USA, 2nd edition, 1997.
  39. M. D. Hendler and S. Saul, The Doctor's Vitamin and Mineral Encyclopedia, Fireside, New York, NY, USA, 1990.
  40. Johns Hopkins University, Johns Hopkins Family Health Book, Harper Collins Publishers, New York, NY, USA, 1999.
  41. C. Collard, Amino Acids: How They Affect the Brain and Nervous System, 2009.
  42. S. A. Nikolayeva, “Use of amino acid compounds in treating epilepsy patients,” REHA-Zentrum, info@aminocure.cz.
  43. N. A. Janjua, H. Kabuto, and A. Mori, “Increased plasma glutamic acid in a genetic model of epilepsy,” Neurochemical Research, vol. 17, no. 3, pp. 293–296, 1992. View at Publisher · View at Google Scholar · View at Scopus
  44. R. X. Moldrich, A. G. Chapman, G. De Sarro, and B. S. Meldrum, “Glutamate metabotropic receptors as targets for drug therapy in epilepsy,” European Journal of Pharmacology, vol. 476, no. 1-2, pp. 3–16, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. J. A. Saugstad and S. L. Ingram, “Group I metabotropic glutamate receptors (mGlu1 and mGlu5),” in The Glutamate Receptors, The Receptors, pp. 387–463, Humana Press, 2008. View at Publisher · View at Google Scholar
  46. N. Flynn, C. J. Meininger, T. E. Haynes, and G. Wu, “The metabolic basis of arginine nutrition and pharmacotherapy,” Biomedicine and Pharmacotherapy, vol. 56, no. 9, pp. 427–438, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. N. N. Abumrad and A. Barbul, “The use of arginine in clinical practice,” in Metabolic and Therapeutic Aspects of Amino Acids in Clinical Nutrition, L. A. Cynober, Ed., pp. 595–611, CRC Press, Boca Raton, Fla, USA, 2004. View at Google Scholar
  48. S. M. Bode-Böger, R. H. Böger, H. Alfke et al., “L-arginine induces nitric oxide—dependent vasodilation in patients with critical limb ischemia: a randomized, controlled study,” Circulation, vol. 93, no. 1, pp. 85–90, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. T. S. Alvares, C. A. Conte-Junior, J. T. Silva, and V. M. F. Paschoalin, “Acute L-arginine supplementation does not increase nitric oxide production in healthy subjects,” Nutrition & Metabolism, vol. 9, article 54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. I. Nissim, O. Horyn, Y. Daikhin et al., “The molecular and metabolic influence of long term agmatine consumption,” The Journal of Biological Chemistry, vol. 289, no. 14, pp. 9710–9729, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Halaris and J. Plietz, “Agmatine: metabolic pathway and spectrum of activity in brain,” CNS Drugs, vol. 21, no. 11, pp. 885–900, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Moretti, F. C. Matheus, P. A. de Oliveira et al., “Role of agmatine in neurodegenerative diseases and epilepsy,” Frontiers in Bioscience—Elite, vol. 6, no. 2, pp. 341–359, 2014. View at Google Scholar · View at Scopus
  53. Y.-F. Chang and N. R. Myslinski, “Effects of l-lysine and its metabolites on pentylenetetrazol-induced seizures,” Neuroscience Letters, vol. 59, no. 1, pp. 79–84, 1985. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. E. Chang, V. Hargest, and J. S. Chen, “Modulation of benzodiazepine by lysine and pipecolic acid on pentylenetetrazol-induced seizures,” Life Sciences, vol. 43, no. 15, pp. 1177–1188, 1988. View at Publisher · View at Google Scholar · View at Scopus